SolusHealthcare data infrastructure
Better-connected information starts with the infrastructure.
A standalone Healthcare opportunity on Graphora.
GRAPHORA VENTURES · PUBLIC OVERVIEWA standalone Healthcare opportunity on Graphora.01 / THE BUSINESS
The opportunity, in focus.
Solus is a healthcare data platform developed by Seamless Integration Group, Inc. It focuses on infrastructure for connecting fragmented information and supporting healthcare workflows.
Graphora · Approved public company overviewConnecting information with healthcare workflows
Connect
Bring healthcare information into connected workflows.
Organize
Support practical access to information across systems.
Evaluate
Review integration readiness, security, and customer evidence.
An editorial summary of the public positioning—not a product-performance assessment.
02 / THE GRAPHORA PERSPECTIVE
Why this belongs in the conversation.
Editorial perspective · Not investment advice
Graphora’s selection perspective is that data integration requires both technical capability and practical understanding of healthcare organizations. Relevant professional experience can help examine the product, adoption path and operating requirements.
03 / MORE THAN CAPITAL
Where members could add value.
Healthcare operations
Insight into the workflows that depend on timely, reliable information.
Data expertise
Experience with interoperability, data quality and implementation.
Partnerships
Relevant relationships for product evaluation and potential commercial collaboration.
What still deserves diligence
Members should examine product readiness, security, integration effort and commercial evidence. Management materials and forecasts require diligence rather than being treated as achieved results.
YOUR NEXT STEP
Explore the member opportunity.
This public overview excludes private financial materials and investment terms. Solus is the product; Seamless Integration Group, Inc. is the company. Access, terms, eligibility, confidentiality, and application availability are checked in the protected member experience.
Public sources reviewed 2026-10-13. This is Graphora’s editorial perspective, not an investment recommendation or an account of an investment committee decision. Company descriptions are attributed statements, not independently verified findings. Imagery is credited to its public source; all marks and images belong to their respective owners.
For information only. Not investment, legal, tax, or medical advice; not an offer, solicitation, recommendation, approval, or guarantee. Private investments may be illiquid and may result in total loss. Listing on Graphora does not establish suitability for any individual.